128 related articles for article (PubMed ID: 21683982)
21. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
22. Giant Cell Ependymoma of Lateral Ventricle: Case Report, Literature Review, and Analysis of Prognostic Factors and Genetic Profile.
Takami H; Graffeo CS; Perry A; Raghunathan A; Jenkins RB; Giannini C; Burns TC
World Neurosurg; 2017 Dec; 108():997.e9-997.e14. PubMed ID: 28943417
[TBL] [Abstract][Full Text] [Related]
23. Metastasizing myxopapillary ependymoma of the sacrococcygeal region. A clinico-pathologic, light- and electronmicroscopic, immunohistochemical, tissue culture, and cytogenetic analysis of a case.
Kindblom LG; Lodding P; Hagmar B; Stenman G
Acta Pathol Microbiol Immunol Scand A; 1986 Mar; 94(2):79-90. PubMed ID: 3716805
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic findings in a supratentorial ependymoma.
Dal Cin P; Sandberg AA
Cancer Genet Cytogenet; 1988 Feb; 30(2):289-93. PubMed ID: 3342386
[TBL] [Abstract][Full Text] [Related]
25. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
[TBL] [Abstract][Full Text] [Related]
26. Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.
Milde T; Pfister S; Korshunov A; Deubzer HE; Oehme I; Ernst A; Starzinski-Powitz A; Seitz A; Lichter P; von Deimling A; Witt O
Genes Chromosomes Cancer; 2009 Mar; 48(3):229-38. PubMed ID: 19025795
[TBL] [Abstract][Full Text] [Related]
27. Rapid spontaneous malignant progression of supratentorial tanycytic ependymoma with sarcomatous features - "Ependymosarcoma".
Vajtai I; Kuhlen D; Kappeler A; Mariani L; Zimmermann A; Paulus W
Pathol Res Pract; 2010 Jul; 206(7):493-8. PubMed ID: 19853384
[TBL] [Abstract][Full Text] [Related]
28. Clinical status epilepticus due to anaplastic cortical ependymoma.
Ohla V; Smith K; Drees C
Clin Neurol Neurosurg; 2012 Jul; 114(6):710-2. PubMed ID: 22209145
[No Abstract] [Full Text] [Related]
29. [Microsurgical treatment of cranial-cervical type giant ependymoma within the fourth ventricle in adult patients].
Yan PX; Wang ZC; Yu CJ; Guan SS
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):628-31. PubMed ID: 15130300
[TBL] [Abstract][Full Text] [Related]
30. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
31.
Pujadas E; Chen L; Weingart JD; Orr B; Ozer BH; Holdhoff M; Rodriguez FJ
Clin Neuropathol; 2020; 39(4):179-187. PubMed ID: 32017698
[TBL] [Abstract][Full Text] [Related]
32. Paediatric intracranial anaplastic ependymoma: the role of multiple surgical resections for disease relapse in maintaining quality of life and prolonged survival.
Kitchen WJ; Pizer B; Pettorini B; Husband D; Mallucci C; Jenkinson MD
Pediatr Neurosurg; 2015; 50(2):68-72. PubMed ID: 25871983
[TBL] [Abstract][Full Text] [Related]
33. Genomic characterization of ependymomas reveals 6q loss as the most common aberration.
Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246
[TBL] [Abstract][Full Text] [Related]
34. Characterization of complex chromosome aberrations in a recurrent meningioma combining standard cytogenetic and array comparative genomic hybridization techniques.
Woo KS; Sung KS; Kim KU; Shaffer LG; Han JY
Cancer Genet Cytogenet; 2008 Jan; 180(1):56-9. PubMed ID: 18068535
[TBL] [Abstract][Full Text] [Related]
35. Giant spinal cord ependymoma with CSF spread.
Su X; Huang QF; Shi W; Chen JG; Chen J
Neurology; 2012 Sep; 79(13):1409. PubMed ID: 23008221
[No Abstract] [Full Text] [Related]
36. Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization.
Espinet B; Salido M; Pujol RM; Florensa L; Gallardo F; Domingo A; Servitje O; Estrach T; Garcìa-Muret P; Woessner S; Serrano S; Solé F
Haematologica; 2004 Feb; 89(2):165-73. PubMed ID: 15003891
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma.
Weremowicz S; Kupsky WJ; Morton CC; Fletcher JA
Cancer Genet Cytogenet; 1992 Jul; 61(2):193-6. PubMed ID: 1638502
[TBL] [Abstract][Full Text] [Related]
38. Chromosome aberrations in four ependymomas.
Sawyer JR; Sammartino G; Husain M; Boop FA; Chadduck WM
Cancer Genet Cytogenet; 1994 Jun; 74(2):132-8. PubMed ID: 8019957
[TBL] [Abstract][Full Text] [Related]
39. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells.
Nijssen PC; Deprez RH; Tijssen CC; Hagemeijer A; Arnoldus EP; Teepen JL; Holl R; Niermeyer MF
J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1245-8. PubMed ID: 7931388
[TBL] [Abstract][Full Text] [Related]
40. Genomic aberrations in pediatric gliomas and embryonal tumors.
Dahlback HS; Brandal P; Gorunova L; Widing E; Meling TR; Krossnes BK; Heim S
Genes Chromosomes Cancer; 2011 Oct; 50(10):788-99. PubMed ID: 21717527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
